Published December 7, 2021 | Version v1
Other Open

Determine research questions and assessment criteria for the preference studies used in the empirical case studies

  • 1. Johnson & Johnson
  • 2. Novartis
  • 3. University Medical Center Utrecht
  • 4. Sanofi
  • 5. University of Rotterdam

Description

This task identified 28 research questions that were considered as highest priority and 39 that were considered second priority, which will be used to formulate the final methodological questions to be evaluated in the empirical case studies and simulation case studies. As part of Task 3.2, additional ranking exercises will further refine the research questions selected, including mapping research questions to suitable empirical case studies and any additional case studies based on sample size and disease context.

Files

115966_PREFER_Deliverable_2.8_final.pdf

Files (755.1 kB)

Name Size Download all
md5:f78b57dfaba5790c0b5acfb9c13b52c2
755.1 kB Preview Download

Additional details

Funding

European Commission
PREFER – Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 115966